| Literature DB >> 30103439 |
Jianhua Wang1,2, Yuanyuan Deng3, Hanyu Diao4.
Abstract
To guarantee the pork quality and safety and the steady development of the pig-breeding industry in China, it is important to control veterinary drugs usage in the pig farming sector. In order to develop an effective intervention that control veterinary drug usage, it is important to perform an in-depth analysis of those factors that can affect the standardized use of veterinary drugs in the pig-breeding process. In this paper, hierarchical regression analysis is used to examine how perceived risk, expected benefits, and self-efficacy influence on the standardized use of veterinary drugs. Data were collected using a multi-stage sampling method from four provinces in China. The results show that expected benefit and self-efficacy have positive impacts on the standardized use of veterinary drugs. Self-efficacy significantly moderated the positive relationships between expected benefits and the negative relationships between perceived risk and standardized use of veterinary drugs.Entities:
Keywords: expected benefits; perceived risk; pig farmers’ behaviors of veterinary drug usage; self-efficacy
Mesh:
Substances:
Year: 2018 PMID: 30103439 PMCID: PMC6121315 DOI: 10.3390/ijerph15081716
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Conceptual framework.
Figure 2Location of the study area.
Basic statistics of samples.
| Statistical Characteristic | Classification Indicator | Sample Size | Percentage (%) |
|---|---|---|---|
| Gender | Male | 235 | 59.2 |
| Female | 162 | 40.8 | |
| Age | 20–30 | 15 | 3.8 |
| 31–40 | 77 | 19.4 | |
| 41–50 | 178 | 44.8 | |
| 51–60 | 110 | 27.7 | |
| ≥61 | 17 | 4.3 | |
| Educational level | Primary School or below | 106 | 26.7 |
| junior middle school | 217 | 54.7 | |
| High school and secondary school | 68 | 17.1 | |
| junior college and above | 6 | 1.5 | |
| Non-Farming Income | Yes | 273 | 68.8 |
| No | 124 | 31.2 | |
| Percentage of Pig-Breeding Incomes in Family Total Income | ≤30% | 131 | 33 |
| 31–50% | 43 | 10.8 | |
| 51–80% | 98 | 24.7 | |
| ≥81% | 125 | 31.5 | |
| Breeding Scale | <50 hogs | 110 | 27.7 |
| 50–500 hogs | 256 | 64.5 | |
| >500 hogs | 31 | 7.8 |
Core variable description and measurement.
| Variable | Item | Factor Loading | Cronbach’ α |
|---|---|---|---|
| Independent Variable | |||
| Expected Benefits | Standardizing the use of veterinary drugs can meet the requirements of pig buyers | 0.802 | 0.779 |
| Standardizing the use of veterinary drugs is safe and risk-free | 0.772 | ||
| Standardizing the use of veterinary drugs is a necessary production process for the production of high-quality pork | 0.749 | ||
| Standardizing the use of veterinary drugs is beneficial to consumers' health and avoids product safety risks | 0.708 | ||
| Standardizing the use of veterinary drugs, the market price of live pigs is high | 0.523 | ||
| Standardizing the use of veterinary drugs can avoid more stringent controls | 0.680 | ||
| Perceived Risk | You are concerned that regulating the use of veterinary drugs is not acceptable to most farmers | 0.780 | 0.717 |
| You are concerned that the regulatory use of veterinary drugs is not effective in preventing the risk of pig disease | 0.714 | ||
| You are worried that regulating the use of veterinary drugs will put your benefits at risk | 0.666 | ||
| You are concerned about the difficulty of regulating the use of veterinary drugs | 0.657 | ||
| Moderator Variable | |||
| Self-efficacy | Your knowledge of the effects of veterinary drugs | 0.823 | 0.800 |
| Your knowledge of pig disease | 0.780 | ||
| According to your ability, it is unlikely that there will be any disease in the process of raising pigs | 0.686 | ||
| You can easily obtain the operation standard information for pig breeding | 0.664 | ||
| You are proficient in the use of veterinary medicine technology and knowledge | 0.611 | ||
| Dependent Variable | |||
| Behavioral Selection | You comply with the regulations on the withdrawal period of veterinary drugs | 0.743 | 0.670 |
| You strictly follow the regulation of a rest period in the process of breeding | 0.730 | ||
| You will conduct regular veterinary drug residue testing or commission monitoring | 0.669 | ||
Variable assignments and descriptive statistics.
| Variable | Assignment Instructions | Mean Value | SD | Minimum Value | Maximum Value |
|---|---|---|---|---|---|
| Gender | Male = 1; Female = 0 | 0.408 | 0.492 | 0 | 1 |
| Age | 20–30 = 1; 31–40 = 2; 41–50 = 3; 51–60 = 4; ≥60 = 5 | 3.093 | 0.887 | 1 | 5 |
| Educational Level | Primary School or Below = 1; Junior high school = 2; High school and secondary school = 3; Junior college = 4; Graduate and above = 5 | 1.945 | 0.747 | 1 | 5 |
| Breeding Scale | Size class (<50 = 1; 50–100 = 2; 100–200 = 3; 200–500 = 4, >500 = 5) | 1.980 | 1.068 | 1 | 5 |
| Perceived Risk | The arithmetical average of earnings risk, functional risk, operational risk, and social risk | 1.720 | 0.556 | 1.250 | 5.000 |
| Expected Benefits | The arithmetic mean values of economic, psychological, and policy gains | 3.400 | 0.686 | 1.667 | 5.000 |
| Self-efficacy | The arithmetic mean of each item | 2.845 | 0.466 | 1.800 | 5.000 |
| Behavioral Selection | Standardized the use of veterinary drugs three dimensional arithmetic mean values | 2.147 | 0.699 | 1.000 | 5.000 |
Descriptive statistics.
| Variable | Perceived Risk | Self-Efficacy | Expected Benefits | Drug Usage | Gender | Age | Educational Level |
|---|---|---|---|---|---|---|---|
| Perceived risk | 1 | ||||||
| Self-efficacy | −0.101 | ||||||
| Expected Benefits | −0.122 * | 0.174 ** | |||||
| Drug Usage | −0.064 | 0.335 ** | 0.258 ** | ||||
| Gender | −0.020 | −0.033 | −0.021 | 0.060 | |||
| Age | 0.066 | −0.091 | −0.184 ** | −0.127 * | 0.036 | ||
| Educational Level | −0.077 | −0.044 | 0.081 | 0.089 | −0.033 | −0.207 ** | |
| Breeding scale | 0.015 | −0.008 | 0.061 | 0.115* | 0.020 | 0.000 | −0.038 |
** and * respectively represent significance at 5% and 10% statistical levels.
Result of hierarchical regression analysis.
| Variables | Model 1 | Model 2 | Model 3 | Model 4 |
|---|---|---|---|---|
| Gender | 0.092 | 0.096 | 0.109 | 0.101 |
| Age | −0.094 * | −0.060 | −0.042 | −0.050 |
| Education Level | 0.108 | 0.089 | 0.126 | 0.091 |
| Breeding Scale | 0.076 * | 0.066 * | 0.070 * | 0.070 * |
| Perceived Risk | − | −0.101 | −0.097 | −0.088 |
| Expected Benefits | − | 0.236 *** | 0.187 *** | 0.177 *** |
| Self-efficacy | − | − | 0.267 *** | 0.250 *** |
| Perceived risk × Self-efficacy | − | − | − | 0.073 ** |
| Expected Benefits × Self-efficacy | − | − | − | 0.044 * |
|
| 0.038 | 0.092 | 0.181 | 0.378 |
| Adjusted | 0.027 | 0.076 | 0.164 | 0.354 |
| 3.491 ** | 5.871 *** | 10.957 *** | 20.499 *** |
***, ** and * respectively represent significant statistical levels of 1%, 5% and 10%.